PAPER Matyi JM, Rattinger GB, Schwartz S, Buhusi M, Tschanz JT
SEARCH RESULTS
3814 RESULTS
PAPER Li H, Yang P, Knight W, Guo Y, Perlmutter JS, Benzinger TL, Morris JC, Xu J
The interactions of dopamine and oxidative damage in the striatum of patients with neurodegenerative diseases.
J Neurochem. 2020 Jan;152(2):235-251. Epub 2019 Nov 4 PubMed: 31613384PAPER Dyer AH, Murphy C, Segurado R, Lawlor B, Kennelly SP, NILVAD Study Group
Is Ongoing Anticholinergic Burden Associated with Greater Cognitive Decline & Dementia Severity in Mild to Moderate Alzheimer Disease?
J Gerontol A Biol Sci Med Sci. 2019 Oct 15; PubMed: 31613323PAPER Wiersma VI, Scheper W
Granulovacuolar degeneration bodies: red alert for neurons with MAPT/tau pathology.
Autophagy. 2020 Jan;16(1):173-175. Epub 2019 Oct 23 PubMed: 31613164PAPER Griner SL, Seidler P, Bowler J, Murray KA, Yang TP, Sahay S, Sawaya MR, Cascio D, Rodriguez JA, Philipp S, Sosna J, Glabe CG, Gonen T, Eisenberg DS
Structure-based inhibitors of amyloid beta core suggest a common interface with tau.
Elife. 2019 Oct 15;8 PubMed: 31612856PAPER Barnes DE, Zhou J, Walker RL, Larson EB, Lee SJ, Boscardin WJ, Marcum ZA, Dublin S
Development and Validation of eRADAR: A Tool Using EHR Data to Detect Unrecognized Dementia.
J Am Geriatr Soc. 2020 Jan;68(1):103-111. Epub 2019 Oct 14 PubMed: 31612463PAPER Jiang X, Chen LL, Lan Z, Xiong F, Xu X, Yin YY, Li P, Wang P
Icariin Ameliorates Amyloid Pathologies by Maintaining Homeostasis of Autophagic Systems in Aβ1-42-Injected Rats.
Neurochem Res. 2019 Dec;44(12):2708-2722. Epub 2019 Oct 15 PubMed: 31612304PAPER Dos Santos Tramontin N, da Silva S, Arruda R, Ugioni KS, Canteiro PB, de Bem Silveira G, Mendes C, Silveira PC, Muller AP
Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer's Disease Model.
Mol Neurobiol. 2020 Feb;57(2):926-936. Epub 2019 Oct 14 PubMed: 31612296PAPER Smith R, Schöll M, Leuzy A, Jögi J, Ohlsson T, Strandberg O, Hansson O
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948.
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):342-354. Epub 2019 Oct 14 PubMed: 31612245PAPER Park J, Baik SH, Mook-Jung I, Irimia D, Cho H
Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil.
Front Immunol. 2019;10:2231. Epub 2019 Sep 25 PubMed: 31611872PAPER Keszycki RM, Fisher DW, Dong H
The Hyperactivity-Impulsivity-Irritiability-Disinhibition-Aggression-Agitation Domain in Alzheimer's Disease: Current Management and Future Directions.
Front Pharmacol. 2019;10:1109. Epub 2019 Sep 27 PubMed: 31611794PAPER Cassano T, Calcagnini S, Carbone A, Bukke VN, Orkisz S, Villani R, Romano A, Avolio C, Gaetani S
Pharmacological Treatment of Depression in Alzheimer's Disease: A Challenging Task.
Front Pharmacol. 2019;10:1067. Epub 2019 Sep 27 PubMed: 31611786PAPER Canet G, Hernandez C, Zussy C, Chevallier N, Desrumaux C, Givalois L
Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets.
Front Aging Neurosci. 2019;11:269. Epub 2019 Sep 27 PubMed: 31611783PAPER Volkman R, Ben-Zur T, Kahana A, Garty BZ, Offen D
Myeloperoxidase Deficiency Inhibits Cognitive Decline in the 5XFAD Mouse Model of Alzheimer's Disease.
Front Neurosci. 2019;13:990. Epub 2019 Sep 24 PubMed: 31611761PAPER Stocker H, Nabers A, Perna L, Möllers T, Rujescu D, Hartmann A, Holleczek B, Schöttker B, Gerwert K, Brenner H
Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors.
Alzheimers Dement. 2020 Feb;16(2):283-291. Epub 2020 Jan 6 PubMed: 31611055Current Filters
- Date Range : Jul 2019 to Oct 2019 x